Interventional News Issue 68 – November 2017 US Edition

80

 Highlights:

  • Big strides in evidence backing prostatic artery embolization
  • Randomised data reveal theoretical benefit with microwave ablation “does not translate into clinical benefit” for hepatocellular carcinoma patients
  • Women largely unaware of uterine fibroid embolisation
  • First patient treated with vandetanib-eluting beads that are visible on CT scans
  • Roberto Iezzi: Future directions for ablation in interventional oncology
  • Julian Soares and Alistair Craig: Changing landscape of IR training in the UK
  • Profile: Andrew Holden

This edition is intended for readers in the USA. For the international edition, please click here

(Visited 36 times, 1 visits today)

LEAVE A REPLY

Please enter your comment!
Please enter your name here